Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Aldeyra The
ALDXCurrent price
4.15 USD
-0.03 USD (-0.72%)
Last closed
4.09 USD
Company
www.aldeyra.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
226 963 392 USD
Yield for 12 month
-45.68 %
1Y
3Y
5Y
10Y
15Y
ALDX
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases. The company also develops ADX-629, an orally administered RASP modulator for treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa, as well as rare retinal diseases characterized by inflammation and vision loss. In addition, it develops ADX-246 in systemic immune-mediated disease; and ADX-248 in geographic atrophy. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts. Address: 131 Hartwell Avenue, Lexington, MA, United States, 02421
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9.25 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+392 620 USD
Current Year
-262 780 USD
Last Year
-258 707 USD
Current Quarter
-60 632 USD
Last Quarter
+326 151 USD
Key Figures ALDX
1 year
3 years
5 years
10 years
EBITDA
-35 128 232 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-14.29 %
PEG Ratio
–
Return On Equity TTM
-23.94 %
Wall Street Target Price
9.25 USD
Revenue TTM
–
Book Value
1.91 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.51 USD
Diluted Eps TTM
-0.51 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ALDX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALDX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ALDX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-3.4975
Price Book MRQ
2.0895
Financials ALDX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALDX
For 52 weeks
1.42 USD
8.38 USD
50 Day MA
3.74 USD
Shares Short Prior Month
2 434 209
200 Day MA
3.43 USD
Short Ratio
6.52
Shares Short
2 542 734
Short Percent
5.15 %
BeatStart